Filter
1893
Filtered Results: 1893
Text search:
Kenya
Ministry
of
Health
Featured
Recommendations
138
New Publications
459
Language
Document type
No document type
1064
Studies & Reports
376
Guidelines
174
Manuals
98
Strategic & Response Plan
76
Training Material
47
Fact sheets
24
Situation Updates
21
Infographics
6
Resource Platforms
4
Brochures
1
App
1
Online Courses
1
Countries / Regions
Kenya
354
Uganda
82
Global
69
Africa
60
Ethiopia
57
Nigeria
48
Rwanda
39
Tanzania
36
Malawi
36
Congo, Democratic Republic of
32
Zambia
32
South Sudan
29
Sierra Leone
21
East and Southern Africa
21
Liberia
20
Zimbabwe
20
Senegal
19
Ghana
18
India
18
South Africa
18
Lesotho
17
Guinea
14
Nepal
14
Mozambique
13
West and Central Africa
13
Somalia
11
Namibia
11
Cameroon
10
Botswana
10
Bangladesh
9
Central African Republic
9
Madagascar
9
Burkina Faso
8
Benin
8
Myanmar / Burma
8
Pakistan
7
Eswatini/ Swaziland
7
Ukraine
7
Cambodia
6
Indonesia
6
South–East Asia Region
6
Western and Central Europe
6
Afghanistan
5
Sudan
5
Middle East and North Africa
5
Asia
5
Côte d’Ivoire / Ivory Coast
4
Togo
4
Syria
4
Angola
4
Yemen
4
Latin America and the Carribbean
4
Russia
4
Mali
3
Philippines
3
Iraq
3
Jordan
3
Chad
3
Thailand
3
Colombia
3
Sri Lanka
3
Eastern Europe
3
Iran
3
Niger
2
Haiti
2
Lebanon
2
Gambia
2
China
2
Brazil
2
Burundi
2
Mexico
2
Eastern Europe and Central Asia
2
Southern Africa
2
Laos
2
Guinea-Bissau
1
Morocco
1
Saudi Arabia
1
Germany
1
Papua New Guinea
1
Vanuatu
1
Argentina
1
Peru
1
North Macedonia
1
Ecuador
1
Greece
1
Western Pacific Region
1
Solomon Islands
1
Palestine
1
North Korea
1
Albania
1
Djibouti
1
Canada
1
Tajikistan
1
Estonia
1
Georgia
1
Vietnam
1
Gabon
1
Japan
1
Mauritius
1
Tunisia
1
Morocco
1
Authors & Publishers
Publication Years
Category
Countries
783
Clinical Guidelines
128
Women & Child Health
118
Public Health
111
Key Resources
75
Capacity Building
44
Pharmacy & Technologies
13
Annual Report MEDBOX
1
Toolboxes
HIV
213
Mental Health
120
Disability
117
COVID-19
117
TB
99
AMR
70
Planetary Health
69
Caregiver
60
Rapid Response
53
NTDs
45
Ebola
39
Conflict
34
Global Health Education
31
Refugee
26
Pharmacy
26
Natural Hazards
18
Health Financing Toolbox
17
NCDs
14
Cholera
12
Polio
8
Social Ethics
7
Zika
2
Specific Hazards
2
South Sudan
1
Health Financing
1
WHO today released its first roadmap to tackle postpartum haemorrhage (PPH) – defined as excessive bleeding after childbirth - which affects millions of women annually and is the world’s leading cause ... maternal deaths.
Despite being preventable and treatable, PPH results in around 70 000 deaths every year. For those who survive, it can cause disabilities and psychological trauma that last for years.
“Severe bleeding in childbirth is one of the most common causes of maternal mortality, yet it is highly preventable and treatable,” said Dr Tedros Adhanom Ghebreyesus, WHO Director-General. “This new roadmap charts a path forward to a world in which more women have a safe birth and a healthy future with their families.”
The Roadmap aims to help countries address stark differences in survival outcomes from PPH, which reflect major inequities in access to essential health services. Over 85% of deaths from PPH happen in sub-Saharan Africa and South Asia. Risk factors include anaemia, placental abnormalities, and other complications in pregnancy such as infections and pre-eclampsia.
Many risk factors can be managed if there is quality antenatal care, including access to ultrasound, alongside effective monitoring in the hours after birth. If bleeding starts, it also needs to be detected and treated extremely quickly. Too often, however, health facilities lack necessary healthcare workers or resources, including lifesaving commodities such as oxytocin, tranexamic acid or blood for transfusions.
“Addressing postpartum haemorrhage needs a multipronged approach focusing on both prevention and response - preventing risk factors and providing immediate access to treatments when needed - alongside broader efforts to strengthen women’s rights,” said Dr Pascale Allotey, WHO Director for Sexual and Reproductive Health and HRP, the UN’s special programme on research development and training in human reproduction. “Every woman, no matter where she lives, should have access to timely, high quality maternity care, with trained health workers, essential equipment and shelves stocked with appropriate and effective commodities – this is crucial for treating postpartum bleeding and reducing maternal deaths.”
Medical devices are used for the prevention, diagnosis and treatment of illness and diseases and for rehabilitation. WHO developed guidance on medical device donation in 2011, which has been now reviewed, with new evidence, new references on conside...
Safe sanitation is essential for health, from preventing infections to improving and maintaining mental and social
well-being. Lack of adequate sanitation contributes to diarrhoeal diseases, parasi...
Water, sanitation and hygiene (WASH) are critical in the prevention and care for all of the 17 neglected tropical diseases (NTDs) scheduled for intensified control or elimination by 2020.
Provision of... safe water, sanitation and hygiene is one of the five key interventions within the global NTD roadmap. Yet to date, the WASH component of the strategy has received little attention and the potential to link efforts on WASH and NTDs has been largely untapped.
Focused efforts on WASH are urgently needed if the global NTD roadmap targets are to be met. This is especially needed for NTDs where transmission is most closely linked to poor WASH conditions such as soil-transmitted helminthiasis, schistosomiasis, trachoma and lymphatic filariasis.
This strategy aims to mobilise WASH and NTD actors to work together towards the roadmap targets.
Provision of... safe water, sanitation and hygiene is one of the five key interventions within the global NTD roadmap. Yet to date, the WASH component of the strategy has received little attention and the potential to link efforts on WASH and NTDs has been largely untapped.
Focused efforts on WASH are urgently needed if the global NTD roadmap targets are to be met. This is especially needed for NTDs where transmission is most closely linked to poor WASH conditions such as soil-transmitted helminthiasis, schistosomiasis, trachoma and lymphatic filariasis.
This strategy aims to mobilise WASH and NTD actors to work together towards the roadmap targets.
Problem Management Plus (PM+)
recommended
Individual psychological help for adults impaired by distress in communities exposed to adversity.
The manual describes a scalable psychological intervention called Problem Management Plus (PM+) for adults impaired by distress in communities who are exposed to adversity. Aspects ... Cognitive Behavioural Therapy (CBT) have been changed to make them feasible in communities that do not have many specialists. To ensure maximum use, the intervention is developed in such a way that it can help people with depression, anxiety and stress, whether or not exposure to adversity has caused these problems. It can be applied to improve aspects of mental health and psychosocial well-being no matter how severe people’s problems are.
This publication is designed to be used by programme planners and managers as a resource when designing interventions to integrate postpartum family planning into national and subnational strategies. Postpartum family planning should not be considered a ‘vertical’ programme, but rather as an int...
2nd edition - Published in 2003, the first WHO/HAI medicine prices manual Medicine Prices – A
New Approach to Measurement Draft for field-testing provides a draft methodology and tools to conduct national medicine prices and availability surveys. This second edition ... the survey manual has been updated to reflect the wealth of practical
experience in conducting medicine prices and availability surveys garnered in the project’s first two phases.
Managing possible serious bacterial infection in young infants when referral is not feasible
recommended
It provides guidance on care for use in resource-limited settings or in settings where families with sick young infants do not accept or cannot access referral care, but can be managed in outpatient settings by an appropriately trained health worker...
The Global Vaccine Action Plan (GVAP) 2011-2020, endorsed by Member States during the May 2012 World Health Assembly, has set ambitious targets to improve access to immunization and tackle vaccine-preventable diseases. This responsibility has been t...
Vitamin D deficiency is thought to be common among pregnant women, particularly during the winter months, and has been found to be associated with an increased risk of pre-eclampsia, gestational diabetes mellitus, preterm birth, and other tissue-spe...
This toolkit for integrated vector management (IVM) is designed to help national and regional programme managers coordinate across sectors to design and run large IVM programmes.
The toolkit provides the technical detail required to plan, implement, monitor and evaluate an IVM approach. IVM can...
The toolkit provides the technical detail required to plan, implement, monitor and evaluate an IVM approach. IVM can...
To complement the Global Strategy progress reporting, this report provides a detailed look at country leadership and action toward the Every Newborn National Milestones by 2020. Countries have taken the initiative to show the way forward and have demonstrated significant progress. As part ... monitoring this progress, countries have adopted the Every Newborn Tracking Tool. This report presents a compilation of the data collated by the Every Newborn Tracking Tool in 2016, when 51 countries adopted the tool; it also spotlights examples of specific country activity for each National Milestone. Finally, Global Milestones for 2020 were part of the Every Newborn Action Plan to guide global and regional work in support of country efforts and this report highlights relevant progress towards those Global Milestones.
Outstanding child and adolescent TB priorities include the need to: find the missing children with active TB and link them to TB care; prevent TB in children who are in contact with infectious TB cases (through implementation of active contact inves...
Suicides take a high toll. Over 800 000 people die by suicide every year and it is the second leading cause of
death in 15-29-year-olds. Most suicides occur in low- and middle-income countries where resources
and services, if they do exist, are of...
This ten year global plan for measles and rubella outlines the strategy that needs to be fully implemented to achieve the measles and rubella goals endorsed by the World Health Assembly. The plan sets out the: vision, goals and targets for the 2011-...
This paper was developed to support AMR coordination committees and others tasked with addressing AMR at country level to do just that. Drawing on the published literature and the operational experience and expertise of different LMICs, the paper po...
Policy brief, 24 July 2020
The COVID-19 pandemic has affected older people disproportionately, especially those living in long-term care facilities. In many countries, evidence shows that more than 40% of COVID-19 related deaths have been linked to...
WHO published the first COVID-19 Strategic Response and Preparedness Plan (SPRP) on 3 February, 2020. This report highlights the main points of progress that were made up to 30 June 2020 under the three objectives outlined in the SPRP: scaling up in...
Just about everyone has experienced the joy that a healthy newborn child brings to parents, families and communities. But the arrival of a newborn who is small or sick often results in immediate wor...
Overcoming barriers in low- and middle-income countries
For the first time, this year’s report includes information on hepatitis C diagnostics. With a focus on selected countries with diverse HCV epidemics, the report provides updates on the various dimensions ... access to HCV diagnostics and pharmaceutical products, including product pricing, the regulatory environment and patent status, which together shape the national hepatitis response in different settings. It highlights key areas for action by ministries of health and other government decision-makers, pharmaceutical manufacturers and technical partners.
